Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

872 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thalidomide: a new anticancer drug?
Fanelli M, Sarmiento R, Gattuso D, Carillio G, Capaccetti B, Vacca A, Roccaro AM, Gasparini G. Fanelli M, et al. Among authors: gasparini g. Expert Opin Investig Drugs. 2003 Jul;12(7):1211-25. doi: 10.1517/13543784.12.7.1211. Expert Opin Investig Drugs. 2003. PMID: 12831355 Review.
Anti-angiogenic and anti-HER therapy.
Gasparini G, Sarmiento R, Longo R. Gasparini G, et al. Biomed Pharmacother. 2006 Jul;60(6):263-5. doi: 10.1016/j.biopha.2006.06.001. Epub 2006 Jun 23. Biomed Pharmacother. 2006. PMID: 16815667 Review.
Targeted therapy of breast cancer.
Longo R, Torino F, Gasparini G. Longo R, et al. Among authors: gasparini g. Curr Pharm Des. 2007;13(5):497-517. doi: 10.2174/138161207780162890. Curr Pharm Des. 2007. PMID: 17348846 Review.
Anti-VEGF therapy: the search for clinical biomarkers.
Longo R, Gasparini G. Longo R, et al. Among authors: gasparini g. Expert Rev Mol Diagn. 2008 May;8(3):301-14. doi: 10.1586/14737159.8.3.301. Expert Rev Mol Diagn. 2008. PMID: 18598109 Review.
Antiangiogenic therapies in breast cancer.
Sarmiento R, D'Andrea MR, Cacciamani F, Salerno F, Gasparini G. Sarmiento R, et al. Among authors: gasparini g. Curr Opin Investig Drugs. 2009 Dec;10(12):1334-45. Curr Opin Investig Drugs. 2009. PMID: 19943205 Review.
The paradigm of personalized therapy in oncology.
Gasparini G, Longo R. Gasparini G, et al. Expert Opin Ther Targets. 2012 Mar;16 Suppl 1:S7-16. doi: 10.1517/14728222.2011.637921. Epub 2011 Nov 11. Expert Opin Ther Targets. 2012. PMID: 22073968 Review.
872 results